Gastroesophageal reflux disease. A step-by-step algorithm for diagnosis and treatment. Review
Modern Gastroenterology · 22.06.2026 · (2) · 84-92
DOI: 10.30978/mg-2026-2-84 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Gastroenterology, online erschienen am 22.06.2026. Verfasst von G. A. Solovyova. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Gastroesophageal reflux disease (GERD) remains one of the most common conditions encountered by gastroenterologists, surgeons, general practitioners, and doctors of other specialties. The diagnosis of GERD requires objective confirmation via endoscopy or reflux monitoring. The criteria confirming the presence of GERD are grade C or D oesophagitis, histologically confirmed Barrett’s oesophagus extending beyond 1 cm, peptic stricture, a previous positive pH monitoring result, and the presence of persistent symptoms. In clinical practice, treatment may be initiated immediately in the presence of typical GERD symptoms and the absence of warning signs and risk factors for Barrett’s oesophagus. In the presence of refractory reflux symptoms, endoscopy, manometry and oesophageal pH monitoring are performed sequentially. In patients without a previous diagnosis of GERD, pH-impedance monitoring is performed without the use of proton pump inhibitors (PPIs) to establish a diagnosis of refractory GERD, hypersensitive oesophagus or functional oesophageal disorder. In patients with a confirmed diagnosis of GERD and refractory symptoms, pH-impedance monitoring is carried out whilst the patient is taking PPIs to diagnose refractory GERD or GERD overlapping with functional disorders or a hypersensitive oesophagus. Proton pump inhibitors are the standard and potent treatments for all forms of GERD. The efficacy of PPIs depends largely on their ability to successfully pass through three ‘barrier’ systems: the gastric acid barrier, the intestinal barrier and the hepatic barrier. The advantages of esomeprazole (Nexium) include its formulation (MUPS), which protects it from hydrochloric acid and accelerates its passage into the intestine and absorption, as well as its metabolism (inhibition of the CYP2C19 isoenzyme), which helps ensure that a greater quantity of the drug reaches the gastric proton pumps and inhibits the majority of them.
Zitieren
APA
Solovyova, G. A. (2026). Gastroesophageal reflux disease. A step-by-step algorithm for diagnosis and treatment. Review. Modern Gastroenterology, 84-92. https://doi.org/10.30978/mg-2026-2-84
Vancouver
Solovyova GA. Gastroesophageal reflux disease. A step-by-step algorithm for diagnosis and treatment. Review. Modern Gastroenterology. 2026:84-92. doi:10.30978/mg-2026-2-84
BibTeX
@article{Solovyova2026,
author = {Solovyova, G. A.},
title = {Gastroesophageal reflux disease. A step-by-step algorithm for diagnosis and treatment. Review},
journal = {Modern Gastroenterology},
year = {2026},
number = {2},
pages = {84--92},
doi = {10.30978/mg-2026-2-84}
}
EUVIMED